Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
Sattar, Naveed, Prof, Preiss, David, PhD, Robinson, Jennifer G, MD, Djedjos, C Stephen, MD, Elliott, Mary, MSc, Somaratne, Ransi, MD, Wasserman, Scott M, MD, Raal, Frederick J, PhD
Published in The lancet. Diabetes & endocrinology (01.05.2016)
Published in The lancet. Diabetes & endocrinology (01.05.2016)
Get full text
Journal Article